Matches in Wikidata for { <http://www.wikidata.org/entity/Q66032661> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q66032661 description "clinical trial" @default.
- Q66032661 description "ensayu clínicu" @default.
- Q66032661 description "klinisch onderzoek" @default.
- Q66032661 description "клінічне випробування" @default.
- Q66032661 name "Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic Cancer" @default.
- Q66032661 name "Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic Cancer" @default.
- Q66032661 type Item @default.
- Q66032661 label "Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic Cancer" @default.
- Q66032661 label "Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic Cancer" @default.
- Q66032661 prefLabel "Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic Cancer" @default.
- Q66032661 prefLabel "Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic Cancer" @default.
- Q66032661 P1050 Q66032661-EEB59237-8A02-4683-971F-D529F191CF33 @default.
- Q66032661 P1132 Q66032661-3AC6EF6C-8EEB-4F06-815E-12E31ACABF40 @default.
- Q66032661 P1476 Q66032661-EA49FC97-8D81-4386-8C1F-88D29DEB653E @default.
- Q66032661 P17 Q66032661-D97E9C84-BC85-4A3B-822C-537DA9F66DD9 @default.
- Q66032661 P2899 Q66032661-FBED5240-92A2-4F47-92F0-59AC68A8CD70 @default.
- Q66032661 P3098 Q66032661-5B3E8A7D-838B-4A6B-90A4-A40B2C4254F0 @default.
- Q66032661 P31 Q66032661-EAD4B4FC-B356-4B2C-8282-5619FA664758 @default.
- Q66032661 P4844 Q66032661-284D86EF-D5B8-4824-BB52-D1966070391B @default.
- Q66032661 P4844 Q66032661-5A76EE3E-8181-45D2-A0EB-2C4E672FCA6A @default.
- Q66032661 P580 Q66032661-959C57C5-9440-4265-A697-34CF4B00A9DA @default.
- Q66032661 P582 Q66032661-0DD5E767-0864-43CC-AD21-EFD06EF5E405 @default.
- Q66032661 P6099 Q66032661-5353A75A-E72C-4006-989E-A92B6B10C7C4 @default.
- Q66032661 P6153 Q66032661-3205FC80-297B-4C66-AFAC-E33A10A9190A @default.
- Q66032661 P8363 Q66032661-469C52DB-01BB-4EC9-B58E-B18C35B50CA9 @default.
- Q66032661 P1050 Q356033 @default.
- Q66032661 P1132 "+143" @default.
- Q66032661 P1476 "A Randomized Phase II Study of Bevacizumab (NSC# 704865) and Gemcitabine in Combination With Either Cetuximab (NSC# 714692) or OSI-774 (NSC# 718781) in Patients With Advanced Pancreatic Cancer" @default.
- Q66032661 P17 Q30 @default.
- Q66032661 P2899 "+18" @default.
- Q66032661 P3098 "NCT00091026" @default.
- Q66032661 P31 Q30612 @default.
- Q66032661 P4844 Q413299 @default.
- Q66032661 P4844 Q50429626 @default.
- Q66032661 P580 "2004-07-01T00:00:00Z" @default.
- Q66032661 P582 "2011-01-01T00:00:00Z" @default.
- Q66032661 P6099 Q42824440 @default.
- Q66032661 P6153 Q131252 @default.
- Q66032661 P8363 Q78089383 @default.